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Abstract
Background: Essential for mitotic growth 1 (EMG1) is a highly conserved nucleolar protein identified in yeast to
have a critical function in ribosome biogenesis. A mutation in the human EMG1 homolog causes Bowen-Conradi
syndrome (BCS), a developmental disorder characterized by severe growth failure and psychomotor retardation
leading to death in early childhood. To begin to understand the role of EMG1 in mammalian development, and
how its deficiency could lead to Bowen-Conradi syndrome, we have used mouse as a model. The expression of
Emg1 during mouse development was examined and mice carrying a null mutation for Emg1 were generated and
characterized.
Results: Our studies indicated that Emg1 is broadly expressed during early mouse embryonic development.
However, in late embryonic stages and during postnatal development, Emg1 exhibited specific expression patterns.
To assess a developmental role for EMG1 in vivo, we exploited a mouse gene-targeting approach. Loss of EMG1
function in mice arrested embryonic development prior to the blastocyst stage. The arrested Emg1
-/- embryos
exhibited defects in early cell lineage-specification as well as in nucleologenesis. Further, loss of p53, which has
been shown to rescue some phenotypes resulting from defects in ribosome biogenesis, failed to rescue the
Emg1
-/- pre-implantation lethality.
Conclusion: Our data demonstrate that Emg1 is highly expressed during mouse embryonic development, and
essential for mouse pre-implantation development. The absolute requirement for EMG1 in early embryonic
development is consistent with its essential role in yeast. Further, our findings also lend support to the previous
study that showed Bowen-Conradi syndrome results from a partial EMG1 deficiency. A complete deficiency would
not be expected to be compatible with a live birth.
Background
Ribosome biogenesis is fundamental to cell growth and
accounts for a substantial proportion of a cell’se n e r g y
expenditure [1]. The ribosomal RNAs (rRNAs) are cen-
tral to the ribosome structure and function [2]. The
rRNA genes exist as tandem repeats and form the foci
upon which the nucleoli form. The rRNA precursor
(47S) is synthesized from the genes by RNA polymerase
I and assembled with ribosomal proteins to form the
90S pre-ribosome. This 90S preribosome is matured to
form the large-60S ribosomal subunit and the small-40S
ribosomal subunit. The 60S subunit contains the 28S,
5.8S and 5S rRNAs as well as approximately 49 proteins,
whereas the 40S subunit contains the 18S rRNA and
approximately 33 proteins. It is estimated that 200 pro-
teins are involved in assembling the mature ribosomes
[3]. Many of them have been studied in yeast, but not in
mammals. Nonetheless, the proteins are highly con-
served and as a starting point, it is reasonable to assume
that they function similarly in mammals.
EMG1 (also known as Nep1) was initially identified as
“Essential for Mitotic Growth” in yeast [4], and later was
shown to be involved in the biogenesis of the mature
40S ribosome [5,6]. Yeast EMG1 (yEMG1) is a 28 kDa
protein primarily detected in the nucleolus [5,6].
Because the deletion of yEMG1 in yeast is lethal, tem-
perature sensitive mutations in this gene have been used
to study the effects of its deficiency. Depletion of
yEMG1 resulted in a reduction in 18S rRNA, a decrease
in 40S ribosomal subunits and an increase in the ratio
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indicate an important role for EMG1 in the biogenesis
of the 40S ribosome.
Deciphering the precise role of EMG1 in 40S ribo-
some biogenesis has been challenging. A temperature
sensitive mutation in yEMG1 could be suppressed by
the methyl donor S-adenosyl methionine (SAM) [6] or
deletion of the snR57 gene encoding a snoRNA needed
for 2’-O-ribose-methylation of G1570 in the 18S rRNA
[7]. Furthermore, yEMG1 was found to interact directly
with snoRNA [8] and the 18S rRNA [9]. Taken together,
these findings suggested that yEMG1 functions to
methylate the 18S rRNA, a concept that was later sup-
ported by the identification of yEMG1 as a SAM-depen-
dent pseudouridine-N1-specific methyltransferase [10].
The EMG1 protein is highly conserved from archae-
bacteria to humans or mice [11]. Expression of the
human orthologue of EMG1 in yeast demonstrates that
it is capable of suppressing the lethal defect in yEMG1
cells, indicating that EMG1 is both structurally and
functionally conserved among these eukaryotes [6].
More recently, a mutation in human EMG1,w h i c hs i g -
nificantly reduces EMG1 protein levels, has been found
to cause Bowen-Conradi syndrome (BCS), an autosomal
recessive disorder characterized by severely impaired
prenatal and postnatal growth, profound psychomotor
retardation, and death in early childhood [12]. This find-
ing strongly suggests that EMG1, as a key molecule
in ribosomal synthesis, could be important for develop-
ment. To get a better understanding of this, in the
present study, we have attempted to generate an EMG1-
deficient mouse and characterize the expression of
Emg1 during mouse development. Our data demon-
strates that EMG1 is essential for mouse pre-implanta-
tion development.
Results and Discussion
Expression of Emg1 during mouse embryogenesis
As a first step toward elucidating the role of EMG1 dur-
ing development, we analyzed the expression of the
Emg1 gene in mouse embryos and postnatal tissues.
Using RNA in situ hybridization, Emg1 expression was
readily detected in E2.5 morula embryos (Figure 1A),
with the strongest expression associated with the inside
cells in the late stage of morula (Figure 1B). High levels
of Emg1 mRNA were also detected in the inner cell
mass (ICM) of mouse blastocysts (E3.5), but not in the
trophectoderm (Figure 1C). This expression pattern is
consistent with Emg1 being expressed highly in the
embryo proper, but weakly expressed or not detectable
in the trophoblasts of mouse placenta (Figure 2).
Expression of Emg1 in mouse pre-implantation
embryos was also analyzed by determining the activity
of LacZ in Emg1 knockout heterozygotes in which the
expression of the LacZ transgene was regulated by the
endogenous Emg1 regulatory elements (see Figure 3).
Crosses of wild-type males with Emg1
+/- females
revealed a positive LacZ signal in zygotes and in 2-cell
embryos, which was not present in those from breeding
Emg1
+/- males with wild-type females (Figure 1D), indi-
cating that these early mouse embryos could contain
maternally transmitted EMG1. However, starting at the
8-cell morula stage, there were two distinct LacZ-stain-
ing patterns for the embryos collected from the breeding
of wild-type males with Emg1
+/- females (Figure 1E).
Among these embryos, Emg1
+/- showed wide-spread
LacZ staining, whereas the ones that were genotyped as
Emg1
+/+ exhibited a weak disperse staining which could
be from residual maternally transmitted LacZ proteins.
This data indicates that the onset of zygotic expression
of EMG1 may occur at the 8-cell morula stage. In addi-
tion, X-gal staining of E3.5 Emg1
+/- blastocysts showed
strong LacZ staining in the ICM, but not in the trophec-
toderm (Figure 1E), which is consistent with Emg1
expression detected by in situ hybridization (Figure 1C).
To determine the expression pattern of Emg1 in post-
implantation embryos, mouse embryos at E8.5-E15.5
were analyzed. At E8.5-E9.5, Emg1 was widely and
strongly expressed and showed no clear tissue-specific
pattern (Figure 2A-B). At later stages (E11.5-E15.5),
however, Emg1 was found to be expressed at a low level
in most embryonic tissues, but strongly in several
regions, including the ventricular zone of the neuroe-
pithelium (Figure 2C), the neural layer of retina
(Figure 2D), the follicles of vibrissae (Figure 2E), thymus
(Figure 2F), submandibular glands (Figure 2G), brown
a d i p o s et i s s u e( F i g u r e2 H ) ,l u n g( F i g u r e2 I ) ,n e p h r i c
tubules and renal mesenchyme (Figure 2J) and semini-
ferous tubules in the testis (not shown).
To examine the expression of Emg1 in extraembryonic
tissue, we performed RNA in situ hybridization on E8.5-
E9.5 mouse placenta. No Emg1 signal was detected in
the trophoblast cells, while a control gene, Rtel (Regula-
tor of Telomere length) showed strong expression in
this cell lineage (Figure 2K) [13].
In adult mice, similar levels of Emg1 mRNA were
detected in multiple tissues by Northern blot hybridiza-
tion (Figure 2L), suggesting that EMG1 could be widely
expressed during postnatal development. However,
using RNA in situ hybridization assays, Emg1 cell-speci-
fic expression patterns were detected in several tissues
(Figure 2M-Q). In the adult testis, Emg1 is highly and
specifically expressed in both spermatogonia and early
meiotic spermatocytes, but not in late stage spermato-
cytes (Figure 2M). A strong Emg1 signal was also identi-
fied in oocytes and the granulosa cells of the pre-antral
follicles in the ovary (Figure 2N). In the adult mouse
brain, Emg1 expression was mainly detected in the
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Page 2 of 14Figure 1 Expression of Emg1 in pre-implantation embryos. (A) Whole mount RNA in situ hybridization of mouse pre-implantation embryos.
Asterisks indicate the E2.5 morulae, and arrows indicate the blastocysts. Hybridization with Emg1 sense probe is presented as a control. (B) High
magnification showing that a stronger Emg1 signal is detected within the inside cells at the morula stage. (C) High magnification demonstrating
that the inner cell mass of the mouse blastocyst is strongly stained with Emg1 antisense probe (arrow indicates), whereas the trophectoderm has
a very low level of Emg1 (arrowhead). (D) Whole mount X-gal staining of zygotes and 2-cell embryos either from the cross of wild-type males
with Emg1
+/- females or from Emg1
+/- males with wild-type females. Only the embryos from the breeding of wild-type males with Emg1
+/-
females show LacZ signals. (E) X-gal staining of morulae and blastocysts collected from the breeding of wild-type males with Emg1
+/- females,
shows wide-spread LacZ signals in the 8-cell morula and in the ICM of Emg1
+/-.I nEmg1
+/+ morulae or blastocysts, only a few cells are weakly
stained for LacZ, probably reflecting a low level of residual maternally transmitted LacZ protein in these cells. Scale bar in A-D, 50μm, and in
E, 100μm.
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Figure 2 Expression of Emg1 in post-implantation embryos and adult mice. (A-B) Whole mount RNA in situ hybridization of post-
implantation mouse embryos (A: E8.5; B: E9.5). (C-J) RNA in situ hybridization on the sections of E13.5-E15.5 mouse embryos, demonstrating that
Emg1 is expressed at low levels in most tissues, but strongly in the ventricular zone of the neuroepithelium (C, arrow indicates), the neural layer
of retina (D), the follicles of vibrissae (E, arrows indicate), thymus (F), submandibular glands (G, arrow indicates), brown adipose tissue (H, arrow
indicates), lung (I, arrow indicates. Asterisk indicates liver in which low expression of Emg1 was found), nephric tubules and renal mesenchyme
(J, arrow indicates). (K) RNA in situ hybridization on the sections of E9.5 placenta, showing that Emg1 mRNA is low or undetectable in the
trophoblast cells (arrow indicates). Rtel antisense probe is presented as a positive control. Magnification for images C-K: x10. (L) Northern blot
analysis of Emg1 expression in mouse adult tissues. Lane: 1 Brain; 2 Lung; 3 Heart; 4 Liver; 5 Spleen; 6 Kidney; 7 Skeletal muscles. Lower panel
shows the total ribosomal RNAs for normalization. (M) RNA in situ hybridization on mouse testis, showing that Emg1 is highly and specifically
expressed in spermatogonia and meiotic spermatocytes. (N) In ovary, strong Emg1 expression is detected in oocyte (arrow indicates). The
granulose cells of the pre-antral follicles are also positive for Emg1 (arrowheads). (O-P) In brain, Emg1 is predominately expressed in the granular
neurons of cerebellum (O, arrow indicates) and the neurons located in hippocampus (P, arrows indicate). (Q) In intestine, Emg1 expression was
mainly identified in the crypts (arrowhead). Magnification for images O-Q: x10.
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Page 4 of 14granular layer of neurons of the cerebellum (Figure 2O)
as well as in the hippocampus (Figure 2P). Specific
expression of Emg1 was also found in the crypts of the
intestine (Figure 2Q).
Taken together, our gene expression data indicates that
EMG1 is broadly distributed in the early developing
embryos, but its expression is more restricted in the later
stages of development. In adult mice, Emg1 also exhibits
cell-specific expression, most notably in the gonads,
brain and intestine. This expression pattern suggests that
EMG1 may not only be important for early embryonic
development, but could also be required for the develop-
ment of several cell lineages at late developmental stages
or during postnatal development.
Generation of the Emg1 null mouse allele
To further study the developmental role of EMG1, we
have mutated Emg1 in mice by homologous recombina-
tion. The mouse Emg1 gene contains 6 exons that
encode a protein composed of 244 amino acids. In
order to create an Emg1 null allele, a gene-targeting vec-
tor with a splice acceptor (SA)-IRES-βgeo-pA cassette
was used to replace exons 2-6 and to remove approxi-
mately 80% of the Emg1 coding sequence (Figure 3A).
Given that Emg1 is highly expressed in ES cells, the
inserted SA-IRESβgeo cassette in the first intron of the
Emg1 locus will trap exon 1 to turn on the expression
of βgeo, a fusion protein of LacZ and neo. This was
designed to allow us to significantly increase the target-
ing frequency, while also allowing us to establish a
mouse allele in which a LacZ reporter is regulated by
the endogenous Emg1 regulatory elements. Indeed,
approximately 25% (11 out of 45) of the ES colonies
obtained after G418 selection showed correct homolo-
gous recombination by Southern blot analysis using
both 5’ and 3’ probes external to the targeting vector
(Figure 3B-C). Furthermore, LacZ transgene expression
in Emg
+/- embryos was entirely consistent with the
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Figure 3 Targeted disruption of EMG1 in mice by homologous recombination. (A) Structure of the wild-type Emg1 locus, the targeting
vector and the mutated locus with exons 2-6 replaced by SA-IRESβgeo cassette. The location of the hybridization probes (5’ probe and 3’ probe)
for Southern blot analyses are shown. (B-C) Southern blot analysis of targeted ES cell clones using the 3’ probe (B) and the 5’ probe (C). (D)
Whole mount X-gal staining of Emg1
+/- embryos (E8.5 and E9).
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Page 5 of 14expression pattern established by in situ hybridization
(Figure 1E and 3D). In this study, we have used two
independently targeted ES lines to generate germline-
transmitting chimeras that were bred with 129S1 or
CD1 females to produce Emg1 null mutants for func-
tional analysis.
The pre-implantation lethality of Emg1 null mutants
Both Emg1
+/- males and females were normal and fer-
tile, and transmitted the targeted allele to about 50% of
their progeny. However, no homozygous offspring were
born from Emg1
+/- intercrosses (Table 1, n = 237), indi-
cating that loss of EMG1 function leads to embryonic
lethality. To determine at which stage of development
the homozygous mutant embryos died, timed heterozy-
gous matings were performed. An analysis of embryos
between E8.5-E12.5 revealed that none of the 64
embryos genotyped were Emg1
-/-. The expected Mende-
lian frequency of heterozygote, homozygote and wild-
type was only observed in the pre-implantation embryos
(Table 1), indicating that mice lacking EMG1 protein
stopped developing at the pre- and/or peri-implantation
stages.
To address this further, we analyzed more than 100
pre-implantation embryos collected from two indepen-
dent mouse lines carrying the Emg1 knockout allele. At
E2.5, Emg1
+/- intercrosses yielded early stage embryos
that were indistinguishable from each other, despite the
presence of Emg1
-/- mutations among these progeny
(Figure 4A). In addition, all the Emg1
-/- embryos at this
developmental stage showed similar BrdU incorporation
(Figure 4B), and nearly undetectable levels of apoptosis,
like that of the wild-type controls (data not shown),
indicating that Emg1
-/- embryos were not blocked at the
E2.5 stage.
The E3.5 embryos from Emg1
+/- intercrosses, however,
consistently showed a mixture of morula and blastocyst-
stage embryos. Genotyping of these embryos demon-
strated that whereas the blastocysts were either Emg1
+/+
or Emg1
+/- heterozygotes, the morula-stage embryos
were Emg1
-/- mutants (Figure 4C). In Emg1
-/- morulae,
the blastomeres flattened and tightly aligned themselves
against each other to form a compact ball of cells.
Immunofluoresence (IF) with anti-E-cadherin antibody
revealed that Emg
-/- morulae exhibited the same orga-
nized pattern of E-cadherin along the cell boundaries as
the wild-type control (Figure 4D). These data indicate
that Emg
-/- embryos do reach the compaction stage of
morula development.
To determine whether Emg1
-/- embryos at E3.5 were
arrested at this stage or simply delayed, we further cul-
tured these embryos in vitro. After 24 h of culture,
while Emg1
+/+ and Emg1
+/- E3.5 embryos formed
expanded blastocysts, none of the E3.5 Emg1
-/-
embryos developed to blastocysts (Figure 4E). Instead,
many cells in the cultured mutant embryos showed
fragmented, pyknotic nuclei, suggestive of cell death.
To determine whether cell death is indeed increased
in these cultured mutant embryos, we performed
a TUNEL assay. A significantly higher number of
TUNEL-positive nuclei were detected in the mutant
embryos than in Emg1
+/+ embryos (Figure 4F). In addi-
tion, very few cells in the cultured mutant embryos
were positive in the BrdU labeling assay (Figure 4G).
These data clearly indicate that Emg1
-/- embryos arrest
prior to forming the blastocyst and subsequently the
embryos undergo degeneration. Because of this severe
phenotype, no Emg1-deficient cells could be estab-
lished to perform further molecular investigations.
Specification of early cell lineages in Emg1
-/- embryos
The failure of Emg1
-/- embryos to form blastocysts could
suggest a defect in the specification of early cell lineages
in these mutant embryos. To test this, we analyzed the
expression of several early cell lineage markers, includ-
ing OCT4, NANOG and CDX2, in E3.5 Emg1
-/-
embryos. These markers have been shown to be widely
expressed in the blastomeres of cleavage stage embryos,
but become restricted to the different lineages, i.e.
OCT4 and NANOG in ICM and CDX2 in trophecto-
derm, after initiation of blastocyst formation [14-17].
Using these lineage markers, we found that although
E3.5 Emg1
-/- embryos did not form the OCT-3/4 or
NANOG-positive ICM like that of Emg1
+/+ blastocysts,
the blastomeres in the mutant embryos displayed levels
of expression of these markers similar to wild type (Fig-
ure 5A and Additional file 1). However, the expression
of CDX2 was consistently found to be significantly
decreased in the mutant embryos as compared to the
controls (Figure 5B). These results suggest that loss of
EMG1 function more specifically down-regulates the
expression of CDX2 in the blastomeres of the cleavage
stage embryos, which might then influence the alloca-
tion or morphogenesis of cell lineages during early
embryogenesis.
Table 1 Genotype analysis of progeny from Emg
+/-
intercrosses
Developmental Stage No. of mice by genotyping Total
+/+ +/- -/-
Postnatal 107 130 0 237
E12.5 6 10 0 16
E9.5 4 13 0 17
E8.5 11 20 0 31
E3.5 11 22 9 42
E2.5 12 17 11 40
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Page 6 of 14Ribosomal biogenesis in Emg1
-/- mutants
EMG1 has been shown to be a highly conserved nucleo-
lar protein required for ribosome biogenesis [5]. Emg1-
null mutants exhibit arrested development prior to the
blastocyst stage, similar to that observed in other mouse
models that lack factors involved in ribosomal RNA
synthesis or processing, including RBM19 (RNA-binding
motif protein 19) [18], pescadillo-1 (PES-1) [19], fibril-
larin [20], RNA polymerase I or II [21], BYSL [22],
SURF6 [23] and RPS19 (ribosomal protein S19) [24].
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Figure 4 Loss of EMG1 function results in pre-implantation arrest. (A) E2.5 embryos collected from Emg1
+/- intercross. These embryos are
indistinguishable from each other, despite the presence Emg1
-/- mutations among these progeny (labeled by arrows). (B) E2.5 Emg
-/- embryos
(indicated by arrows) display the similar BrdU incorporation as Emg1
+/+ or Emg1
+/- littermates. (C) E3.5 embryos collected from Emg1
+/-
intercross, showing that Emg1
-/- embryos arrest at the morula stage (labeled by asterisks), and fail to form an inner cell mass, trophectoderm cell
layer and blastocoel cavity as wild-type or Emg1
+/- embryos. (D) Immunofluoresence with anti-E-cadherin antibody, showing that Emg
-/- morulae
exhibit the same organized pattern of E-cadherin along the cell boundaries as wild-type littermates. (E) In vitro culture of E3.5 embryos from
Emg1
+/- intercross. None of Emg1
-/- embryos develop into blastocyst (indicated by asterisks). (F) Whole mount TUNEL assay shows the high levels
of apoptosis in E3.5 Emg1
-/- embryos after 24-hour culture. Few TUNEL-positive cells (indicated by arrows) are detected in wild-type littermate.
(G) BrdU labeling assay to demonstrate the lack of cell proliferation in the cultured mutant embryos. Green: BrdU; Blue: Dapi. Scale bar in A-C
and E-F, 100μm.
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Figure 5 Characterization of the early embryonic lineages in Emg1
-/- mutant embryos. (A) Immunofluorescence staining with anti-OCT-3/4
antibody, demonstrating that E3.5 Emg1
-/- embryos do not form the OCT-3/4-positive inner cell mass (ICM) like the wild type blastocyst, but
display a similar level of OCT-3/4 expression as wild type controls. (B) Immunofluorescence staining with anti-CDX2 antibody, showing that CDX2
is weakly expressed in the blastomeres of mutant embryos as compared to Emg1
+/+ blastocysts or morulae.
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demonstrated to cause severe defects in ribosomal bio-
genesis [19,21,22]. Thus, loss of EMG1 function in mice
could also disrupt this biological pathway, leading to
pre-implantation lethality.
To address this question, we first determined whether
loss of EMG1 could affect nucleologenesis during pre-
implantation development. As demonstrated previously,
“de novo” nucleologenesis which begins at the two-cell
stage is critical for the resumption of rRNA transcrip-
tion during early embryogenesis [25-27]. This process
involves the morphological transformation of the
nucleolus precursor body (NPB) to a mature, tripartite
nucleolus as seen in the blastocysts [27,28]. To deter-
mine the effect of the Emg1 gene-deletion on nucleolo-
genesis, we performed IF staining for the nucleolar
makers B23/nucleophosmin and fibrillarin in E3.5
embryos harvested from Emg1
+/- intercrosses. As shown
in Figure 6, in E3.5 Emg1
+/+ or Emg1
+/- embryos, the
nucleoli are smaller and more irregular than NPBs in
E2.5 morula, indicating a striking maturation occurred
at this developmental stage. In contrast, the nucleoli in
E3.5 Emg1
-/- embryos still showed the large ring shape,
closely resembling the NPBs observed in E2.5 wild-type
morula. Therefore, these data strongly suggest that dele-
tion of the Emg1 gene arrests nucleologenesis during
early embryonic development.
To determine if Emg1
-/-embryos exhibit defective 40S
ribosome biogenesis, similar to yeast depleted in
yEMG1, we examined the level of mature 18S rRNA
using reverse transcription (RT) followed by PCR.
Although the levels of 18S rRNA are significantly
reduced in yeast depleted in yEMG1, no detectable
decrease in 18S rRNA were detected in Emg1
-/- morulae
at E2.5 as compared to wild-type embryos at the same
developmental stage (Figure 6B). Since E2.5 mouse
morulae could contain residual maternal rRNAs, we
used the same approach to analyze 18S rRNA in E3.5
Emg1
-/- embryos as compared to wild-type embryos
with the same developmental stage. Again, no difference
was observed (Figure 6C). Given that the levels of 18S
rRNA in cells are very high, and small differences
would not be detectable using this assay, we also looked
for an increase in the precursors to the 18S rRNA, the
pre-rRNA, but again no obvious difference between
Emg1
-/- and wild type or heterozygous embryos was
detected (Figure 6C). The unchanged expression of 18S
rRNA and 47S rRNA in Emg1
-/- embryos was also indi-
cated by RT followed by real-time PCR analysis (data
not shown). Although this data differs from that in
yeast, it is still possible that there is a delay in riboso-
mal RNA processing or assembly that was not detected
using these assays. More sensitive approaches such as
metabolic labeling or pre-rRNA specific probes may be
required to show a delay in rRNA processing, as was
r e c e n t l ys h o w ni nt h es t u d yo fap r o t e i nr e q u i r e df o r
the maturation of the 60S ribosomal subunit in human
cells [29]. However, due to the early pre-implantation
lethality of the Emg1 null allele, we are unable to derive
EMG1-deficient cells in which to perform these assays.
Future experiments with a conditional knockout
of EMG1 will greatly help to address the role of EMG1
in the regulation of ribosomal biogenesis during
development.
P53 deficiency does not rescue the pre-implantation
arrest of Emg1
-/- mice
Previous studies have found that mutations in many
proteins involved in ribosome biogenesis lead to an up-
regulation of p53 [30-32], a key regulator of the cell
cycle and apoptosis. The importance of p53 in the regu-
lation of ribosome biogenesis has been addressed by
studies showing that inhibition of p53 can suppress the
effects of some defects in ribosome biogenesis. In mice,
p53 inhibition was found to suppress the effects of
mutation of Tcof (Treacher Collins syndrome-causing
g e n e )[ 3 3 ]a n dRps24 (Diamond-Blackfana n e m i a - c a u s -
ing gene) [34]. These findings suggest that the inhibi-
tion of p53 may suppress the detrimental effects of
mutations in other disorders of ribosomal biogenesis,
such as EMG1 deficiency. To test this, E3.5 embryos
were collected from intercrosses of Emg1/p53 double
heterozygotes (Emg1
+/-/p53
+/-)o rEmg1
+/-/p53
-/-. A total
of 5 Emg1
-/-/p53
-/- E3.5 embryos were identified, and all
of them were found to be arrested at morula stage like
the Emg
-/- null mutants (Additional file 2). In addition,
none of E3.5 Emg1
-/-/p53
-/- embryos developed to blas-
tocysts during in vitro culture. Taken together, these
data demonstrate that p53 inactivation fails to rescue
the pre-implantation arrest of the Emg1 null allele.
In summary, we have demonstrated that EMG1 is essen-
tial for mouse pre-implantation. We showed that loss of
EMG1 function specifically arrests early embryonic devel-
opment at the morula stage, preventing blastocyst forma-
tion. This phenotype is consistent with our expression
data showing that Emg1 is highly expressed during this
critical developmental stage. However, due to the high
expression of Emg1 in mouse oocytes (Figure 2N), which
could be maternally transmitted into early developing
embryos like other nucleolar components [35] (Figure
1D), we could not exclude the possibility that EMG1 is
also required before the morula stage. Future experiments
with a conditional knockout of EMG1 specifically in
mouse oocytes will allow us to answer this question.
Nevertheless, our study highlights a critical role of EMG1
in mouse early embryonic development.
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Figure 6 Characterization of nucleologenesis and ribosomal synthesis in Emg1
-/- embryos. (A) Immunofluorescence staining for the
nucleolar markers B23/nucleophosmin and fibrillarin. In E3.5 Emg1
+/+ embryos, the nucleoli are smaller and more irregular than the NPBs in E2.5
morulae. The nucleoli in E3.5 Emg1
-/- mutants, however, display a large sphere shape, which closely resemble NPBs as seen in E2.5 wild-type
embryos. (B) RT-PCR on E2.5 morulae harvested from Emg1
+/- intercrosses. Arrows indicate the morulae that lack Emg1 mRNA but show a similar
level of 18S rRNA to that of Emg1-expressing morulae. The genotypes for each sample are also presented. M: 50 bp or 100 bp DNA markers. (C)
RT-PCR on E3.5 Emg
-/- embryos, showing similar levels of 18S rRNA and pre-rRNA in both mutant and wild-type embryos.
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been demonstrated by our recent finding that this gene
is mutated in human BCS syndrome, a severe develop-
mental disorder with prenatal and postnatal growth
retardation, profound psychomotor deficit, and death in
early childhood [36]. Because of this mutation, the
EMG1 protein was found to be significantly reduced in
fibroblasts of BCS patients [12]. The residual protein
that is detected is likely necessary to allow survival, as
mice with a complete deficiency of EMG1 exhibit pre-
implantation lethality. Therefore, the involvement of
EMG1 in development could be dose-dependant. The
hypomorphic mutation of EMG1 in BCS could specifi-
cally affect late embryonic development or certain cell
lineages to cause BCS-associated phenotypes. In line
with this, in this study, we found that Emg1 is predomi-
nately expressed in distinct cell types at late embryonic
developmental stages or in adult (Figure 2). The unique
expression of Emg1 in the granular neurons of cerebel-
lum or in hippocampus could underly an important role
for EMG1 in the control of psychomotor development,
whose dysfunction is characteristic of BCS. Future
experiments with mouse alleles to allow knockin of the
BCS mutation, or a conditional allele, will allow us to
address the pathological role(s) of EMG1 in vivo.
Conclusions
We have provided direct genetic evidence that EMG1 is
essential for mouse pre-implantation. Given the require-
ment of yEMG1 in the biogenesis of the ribosomal 40S
subunit, our study also highlights the critical role of
ribosomal biogenesis in early development. The absolute
requirement for EMG1 in mouse development is consis-
tent with its essential role in yeast. Further, our findings
also lend support to the previous study that showed
Bowen-Conradi syndrome results from a partial EMG1
deficiency. A complete deficiency would not be expected
to be compatible with a live birth.
Methods
Construction of the Emg1 gene-targeting vector
The Emg1 gene-targeting vector was made based on a
PCR-based cloning strategy as described previously [37].
Briefly, the mouse Emg1 genomic fragments required for
the 5’ and 3’ arms of homology were PCR-amplified from
the genomic DNA of R1 ES cells (on 129S1 background)
with a high-fidelity polymerase (Clontech). After valida-
tion by DNA sequencing, the PCR products were cloned
into two individual vectors that contain the SA-IRESβgeo
cassette, and a pGKDTA fragment (the negative selection
cassette), respectively. Subsequently, using the restriction
enzymes and the cloning strategy as described [37], the
DNA fragments were isolated, and assembled together to
generate the gene-targeting vector.
Generation of Emg1 deficient mice
The Emg1 gene-targeting construct was linearized and
electroporated into R1 ES cells, and then selected with
G418 (250 μg/ml). The G418 resistant ES clones were
screened by Southern blot analysis for the correctly tar-
geted allele using EcoR1 (for the 5’ external probe) and
BamH1 (for the 3’ external probe) digestion. Two inde-
pendently targeted ES cell clones were used to generate
chimeric mice that subsequently transmitted the genetic
alternation through the germ line. The phenotypes of
Emg1
-/- mutants derived from both targeted ES cell lines
were indistinguishable. Mice were maintained on either
129S1 or on a mixed 129S1 and CD1/ICR background,
in which Emg1
-/- developed the same phenotype. All
mouse experiments were performed in accordance with
procedures approved by the University of Manitoba
Animal Care and Use Committee.
Genotyping
PCR and Southern blot analysis were applied for geno-
typing the Emg1 heterozygous mice. PCR was performed
on ear-punched DNA. Primers to amplify the targeted
allele were the sense primer (P1), located in intron 2
(5’-GTTCCTCAGCATATACGTGCT-3’) and antisense
primer (P2) specific for the SA-IRESβgeopA cassette
(5’-GGGACAGGATAAGTATGACATCA-3’). To detect
the wild-type Emg1 allele, P1 primer and an antisense
primer (P3) locating in exon 2 (5’-TGTAAACCTGTAG-
CAAGCCAGCT-3’) were used for PCR. Southern blot
analysis was undertaken using standard protocols.
To genotype pre-implantation mouse embryos, a
nested PCR method was applied. DNA was prepared by
incubating E2.5-E3.5 embryos with 10 μl of Proteinase K
b u f f e r( 1 0m MT r i sp H8 . 3 ,5 0m MK C l ,2m MM g C l 2,
0.01% gelatin, 0.45% Nonidet P40, 0.45% Tween 20 and
500 μg/ml proteinase K) for 1 h at 55°C followed by
incubation at 95°C for 10 min. 5 μl of DNA sample was
then directly used for PCR using P1 and P2 (for the
Emg1 targeted allele) and P1 and P3 (for the wild-type
allele). 2 μl of products from the first round PCR were
further PCR-amplified with the internal primers, gener-
ating 264 bp (wild-type allele) and 353 bp (targeted
allele) products, respectively.
A similar approach was also applied to genotype the p53
null allele in Emg1/p53 double mutant pre-implantation
embryos. The first round PCR was done using the primers
as described previously [38]. In the second round PCR, the
following internal primers were utilized: 5’-TACCTCAC-
TACAGGTGACCTG-3’ (sense) and 5’-TCTTAGAGA-
CAGTTGACTCCAG-3’ (antisense) (for detecting the p53
wild-type allele), and 5’- TACCTCACTACAGGT-
GACCTG-3’ (sense) and 5’-GTGATATTGCTGAA-
GAGCTTGG-3’ (antisense) (for detecting the p53 null
allele).
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Page 11 of 14Early embryo isolation and in vitro culture
Emg1
+/- or Emg1
+/-/p53
+/- mice were intercrossed, and
the females were examined for the presence of a vaginal
plug which was set as embryonic day (0.5). Embryos at
different stages of development (E2.5 through E3.5)
were collected by either dissecting ampullae or flushing
oviducts with M2 medium (Millipore). For in vitro cul-
turing, E3.5 embryos were placed in KSOM-1/2AA
medium (Millipore), and incubated at 37°C for 24 h.
Immuno-staining of pre-implantation embryos
Immuno-staining of pre-implantation embryos was per-
formed based on the protocols provided by Dr. Janet Ros-
sant http://www.sickkids.ca/research/rossant/custom/
protocols.asp. The following antibodies were used: mono-
clonal anti-CDX2 (1:200, CDX2-88, BioGenex, CA, USA),
monoclonal mouse anti-OCT3/4 (1:50, C10; Santa Cruz
Biotechnology), rabbit anti-NANOG (1:200, Cosmo Bio),
Rat anti-E-cadherin (1:100, Sigma), monoclonal mouse
anti-B23 (1:50, Invitrogen) and rabbit anti-fibrillarin
(1:100, Abcam). Secondary antibodies included Texas
Red or Alexa488-conjugated goat anti-mouse, goat anti-
rat and goat anti-rabbit (Molecular Probes). To visualize
nuclei, embryos were stained with DAPI (0.5μg/ml) for 3
m i na tr o o mt e m p e r a t u r e .I m m u n o - s t a i n e de m b r y o s
were mounted onto microscopic slides with ProLong
Gold (Invitrogen) and covered with glass cover slips.
Images were collected using a Zeiss Axioplan 2 micro-
scope to generate Z-stacks which were deconvolved
using iterative algorithms program in Axio Vision 4.6.
For the BrdU labeling assay, E2.5-E3.5 embryos were
incubated with KSOM-1/2AA medium containing 10
μM BrdU (Sigma) for 3 h, and were then fixed in 4%
paraformaldehyde (PFA) for 10 min, permeabilized in
0.25% Triton X-100 for 10 min, treated with 2N HCl for
10 min, and detected with anti-BrdU antibody (Sigma).
TUNEL staining
E2.5-E3.5 mouse embryos were fixed in 4% PFA in PBS
for 1 h at room temperature, and permeabilized for 1 h
in PBS-0.5% Triton X-100. The embryos were then
washed three times in PBS-0.1% Trion X-100 and incu-
bated at 37°C for 1 h in a staining solution containing
biotin-dUTP, terminal deoxynucleotide transferase
(TdT), and detected using an ABC staining kit (Vector).
Whole mount x-gal staining
Pre-implantation embryos were fixed for 2 min with 1%
PFA, 0.2% glutaraldehyde and 0.02% NP40 in PBS. After
fixation, embryos were washed three times with PBS con-
taining 0.02% NP40, and stained at 37°C overnight with a
staining solution (4 mM K4Fe(CN)6, 4 mM K3Fe(CN)6,2
mM MgCl2, and 0.2% X-gal in PBS). For E8.5-E9.5
embryos, embryos were fixed for 30 min with 4% PFA.
After extensive washing with PBS containing 0.02% NP40
(three times, 20 min/each time), embryos were stained as
described above.
RNA in situ hybridization
RNA in situ analysis of whole mount mouse embryos
and frozen sections of mouse tissues were performed
according to established protocols [39] with antisense
and sense digoxigenin-labeled riboprobes which were in
vitro transcribed from the full-length mouse Emg1 cod-
ing sequence. Mouse embryos were collected from preg-
nant outbred ICR female mice at E9.5-E15.5 days of
gestation, and the adult tissues were harvested from
two-month old ICR mice. All the samples were fixed in
DEPC-treated 4% PFA at 4°C overnight.
RNA in situ hybridization on early mouse embryos
(E2.5-E3.5) was performed essentially based on a
described protocol [40]. To preserve the pre-implanta-
tion embryos, the whole procedure was carried out in a
transwell-insert (Corning).
Northern Blot Analysis
Total RNA from flash-frozen mouse tissues was
extracted using TRIzol (Life Technologies, Inc.). 20 μg
of total RNA was separated on a 1% agarose-formalde-
hyde gel and transferred to Hybond nylon membrane
(Amersham). Hybridization was carried out in Per-
fectHyb (Sigma) with 1.5×10
6 cpm/ml probe which cov-
ers the whole coding sequence of Emg1.
RT-PCR analysis of pre-implantation embryos
Each blastocyst or morula was lysed with 5 μl ice-cold
Cell Lysis II Buffer (Ambion) for 10 min at 75°C. 2 μlo f
lysate was used for PCR based genotyping, the rest was
digested with DNase1 (0.08 unit/μl, Ambion) at 37°C for
15 min. After inactivation at 75°C for 5 min, 2 μlo f
DNase1-treated embryonic lysate was used in an RT
reaction in a 10 μl volume using the OneStep RT-PCR
kit (Qiagen) according to the manufacturer’si n s t r u c -
tions. The final concentration of specific primers
(see the reverse primers described below) was 0.6 μM
each. 2 μl RT mixture were then used for PCR reactions
with the Multiplex PCR kit (Qiagen) and the primers
described below. The PCR cycles contain an initial
denaturation step of 95°C for 15 min and 40 cycles of
94°C for 30 s, 60°C for 90 s, and 72°C for 60 s, and a
f i n a l1 0m i ne x t e n s i o ns t e pa t7 2 ° C .T h eP C Rp r o d u c t s
were separated on a 12% polyacrylamide gel in 1× Tris-
borate-EDTA buffer. The bands on the gel were visua-
lized by the silver staining method as described [41].
The following primers were used for the above RT-PCR
analysis: Mouse Emg1: forward (5’-TGAAGTGAACCCC-
CAGACTC-3’) and reverse (5’-GAAGTGGTCGGACAC-
TGGAT-3’). The amplified DNA band is 148 bp. Mouse
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3’) and reverse (5’-TGATACGGGCAGACACAGAA-3’)
in the 5’ external transcribed spacer (5’-ETS) region of
mouse 47S pre-rRNA [42]. The size of the PCR product
is 105 bp. Mouse 18S rRNA: forward (5’-GCAAT-
TATTCCCCATGAACG-3’) and reverse (5’-GGCCTC
ACTAAACCATCCAA-3’), which gives rise to a DNA
band with 123 bp.
Additional material
Additional file 1: Expression of NANOG in Emg1
-/- mutant embryos.
E3.5 embryos from Emg1
+/- intercross were co-immunostained with anti-
NANOG (red) and anti-β-catenin (green) antibodies. In E3.5 Emg1
+/+
blastocysts, nuclear-localized NANOG is mainly found in the ICM. NANOG
is also detected in the blastomeres of E2.5 Emg1
+/+ morulae. At E3.5,
Emg1
-/- embryos arrest at the morula stage, in which the blastomeres
express similar levels of NANOG as that in E2.5 Emg1
+/+ morulae.
Additional file 2: p53 inactivation fails to rescue the pre-
implantation arrest of the Emg1 null allele. E3.5 embryos were
collected from intercross of Emg1
+/-/p53
+/- (A) and cross of Emg1
+/-/p53
-/-
(male) with Emg1
+/-/p53
+/- (female) (B). In both, Emg1
-/-/p53
-/- embryos
show the same morula arrest as Emg
-/-/p53
+/- or Emg
-/-embryos. Scale
bar, 100μm.
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